thyroid medication and glp 1 Hashimoto's GLP-1: what patients need to know before starting GLP-1 medications and thyroid cancer

CagriSema is Novo Nordisks answer to the same challenge

In response to CNAs queries, Shopee said these product listings are misleading and not allowed on the e-commerce platform

this is just people's weight, you know, before they started and then, you know, once they started doing every other week," Biermann said

For patients using licensed injectable GLP-1 receptor agonists who have concerns about their treatment, contact your GP or diabetes care team for advice

Patients should seek medical guidance promptly for severe abdominal pain, persistent vomiting, signs of dehydration, symptoms of gallbladder problems, allergic reaction symptoms, or any concerning change after starting medication

Clinical trials demonstrate that patients receiving liraglutide showed 18% slower cognitive decline over one year compared to placebo 30